About Us

The foundation of UroCellZ Research dates back to 2011, when Dr. Michael P. Zahalsky started investigating and researching the use of stem cells and biologics in the field of Urology. During Dr. Zahalsky’s fellowship in Erectile Dysfunction and Sexual Medicine at Boston University, he also performed genetic research at MIT. Combining these expertise with his Masters focusing on Epidemiology from Brown University, this made him the perfect physician to continue research in this novel field.

He studied multiple sources of stem cells and biologic products, seeking medical and legal opinions on them. Understanding the FDA regulations and opinions on human tissue was very important to him, assisting him in his quest to find autologous products for homologous use.

In 2013, Dr. Zahalsky conducted the first human study in America using Placental Matrix and Stem Cells for Erectile Dysfunction, and the first human study in the world using Placental Matrix and Stem Cells for Peyronie’s Disease. These results have been presented at National and International Conferences and have been published and accepted for publication in The Journal of the American Osteopathic Association.

Dr. Zahalsky is now considered the world’s leading expert in the field of Regenerative Medicine and how it is used for Erectile Dysfunction and Peyronie’s Disease. UroCellZ was incorporated in 2015 to assist Dr. Zahalsky in his goal of changing the field of Sexual Medicine by using biologic products.

Dr. Zahalsky has now put together an advisory board to help him further advance the science and knowledge surrounding Biologics in Urology. All the physicians on this board are themselves considered experts in their fields.

Through education and research, UroCellZ Research plans to advance Sexual Medicine and Urology by introducing biologics into Urology.

* This web site is a repository of publicly available information, and is not intended to form a physician-patient relationship with any individual. Individual urologic conditions, treatment and recovery times may vary. The information presented on this web site is not intended to take the place of your personal physician’s advice and is not intended to diagnose, treat, cure or prevent any disease. Discuss this information with your own physician or healthcare provider to determine what is right for you. The information contained herein is presented in summary form only and intended to provide broad consumer understanding and knowledge. Each patient’s experience with procedures described herein will differ.**Statements, treatments and other information on this web site have not been evaluated by the US Food & Drug Administration. The stem cell protocols we offer, using autologous bone marrow-, autologous adipose- and allogeneic human umbilical cord-derived stem cells amniotic, are not approved in the United States as treatments, therapies, drugs, new drugs or investigational drugs. All information on this web site is provided for informational purposes only. We do not claim that our treatment protocols are approved by the US FDA or proven to be effective in the United States for any condition that appears on this site or for any other condition. There could be significant and unknown risks associated with adult stem cell treatments, as long-term studies have not been performed. Very few, randomized clinical trials of adult stem cells have been performed, therefore no guarantee of safety or effectiveness is made or implied.***The opinions expressed in patient testimonials are by patients only; they are not qualified medical professionals. These opinions should not be relied upon as, or in place of, the medical advice of a licensed doctor or other health care provider.